Casserly B - Search Results

1

C-type natriuretic peptide does not attenuate the development of pulmonary hypertension caused by hypoxia and VEGF receptor blockade.

Casserly B, Mazer JM, Vang A, Harrington EO, Klinger JR, Rounds S, Choudhary G. Casserly B, et al. Life Sci. 2011 Sep 26;89(13-14):460-6. doi: 10.1016/j.lfs.2011.07.009. Epub 2011 Jul 27. Life Sci. 2011. PMID: 21820448 Free PMC article.

2

Cardiac atria are the primary source of ANP release in hypoxia-adapted rats.

Casserly B, Pietras L, Schuyler J, Wang R, Hill NS, Klinger JR. Casserly B, et al. Life Sci. 2010 Sep 11;87(11-12):382-9. doi: 10.1016/j.lfs.2010.07.013. Epub 2010 Aug 5. Life Sci. 2010. PMID: 20691705 Free PMC article.

3

Rottlerin causes pulmonary edema in vivo: a possible role for PKCdelta.

Klinger JR, Murray JD, Casserly B, Alvarez DF, King JA, An SS, Choudhary G, Owusu-Sarfo AN, Warburton R, Harrington EO. Klinger JR, et al. Among authors: casserly b. J Appl Physiol (1985). 2007 Dec;103(6):2084-94. doi: 10.1152/japplphysiol.00695.2007. Epub 2007 Sep 27. J Appl Physiol (1985). 2007. PMID: 17901241 Free article.

4

Pulmonary endothelial cell signaling and function.

Rounds S, Lu Q, Harrington EO, Newton J, Casserly B. Rounds S, et al. Among authors: casserly b. Trans Am Clin Climatol Assoc. 2008;119:155-67; discussion 167-9. Trans Am Clin Climatol Assoc. 2008. PMID: 18596849 Free PMC article.

5

Ambrisentan for the treatment of pulmonary arterial hypertension.

Casserly B, Klinger JR. Casserly B, et al. Drug Des Devel Ther. 2009 Feb 6;2:265-80. doi: 10.2147/dddt.s3057. Drug Des Devel Ther. 2009. PMID: 19920913 Free PMC article.

6

Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent.

Casserly B, Klinger JR. Casserly B, et al. Drug Des Devel Ther. 2009 Dec 29;3:269-87. doi: 10.2147/dddt.s4805. Drug Des Devel Ther. 2009. PMID: 20054445 Free PMC article.

7

Adenosine protected against pulmonary edema through transporter- and receptor A2-mediated endothelial barrier enhancement.

Lu Q, Harrington EO, Newton J, Casserly B, Radin G, Warburton R, Zhou Y, Blackburn MR, Rounds S. Lu Q, et al. Among authors: casserly b. Am J Physiol Lung Cell Mol Physiol. 2010 Jun;298(6):L755-67. doi: 10.1152/ajplung.00330.2009. Epub 2010 Mar 12. Am J Physiol Lung Cell Mol Physiol. 2010. PMID: 20228181 Free PMC article.

8

Activation of endothelial BKCa channels causes pulmonary vasodilation.

Vang A, Mazer J, Casserly B, Choudhary G. Vang A, et al. Among authors: casserly b. Vascul Pharmacol. 2010 Sep-Oct;53(3-4):122-9. doi: 10.1016/j.vph.2010.05.001. Epub 2010 May 12. Vascul Pharmacol. 2010. PMID: 20470901

9

Echocardiographic evidence of pulmonary hypertension is associated with increased 1-year mortality in patients admitted with chronic obstructive pulmonary disease.

Stone AC, Machan JT, Mazer J, Casserly B, Klinger JR. Stone AC, et al. Among authors: casserly b. Lung. 2011 Jun;189(3):207-12. doi: 10.1007/s00408-011-9293-4. Epub 2011 May 10. Lung. 2011. PMID: 21556789

10

Role of protein tyrosine phosphatase SHP2 in barrier function of pulmonary endothelium.

Grinnell KL, Casserly B, Harrington EO. Grinnell KL, et al. Among authors: casserly b. Am J Physiol Lung Cell Mol Physiol. 2010 Mar;298(3):L361-70. doi: 10.1152/ajplung.00374.2009. Epub 2009 Dec 18. Am J Physiol Lung Cell Mol Physiol. 2010. PMID: 20023173 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters